139 related articles for article (PubMed ID: 2137621)
1. Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.
Shaw RW
Prog Clin Biol Res; 1990; 323():383-92. PubMed ID: 2137621
[TBL] [Abstract][Full Text] [Related]
2. [Goserelin depot: an analog of LHRH for the treatment of endometriosis].
Shaw RW
Drugs Exp Clin Res; 1990; 16 Suppl():69-75. PubMed ID: 2150504
[No Abstract] [Full Text] [Related]
3. Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
Reichel RP; Schweppe KW
Fertil Steril; 1992 Jun; 57(6):1197-202. PubMed ID: 1534773
[TBL] [Abstract][Full Text] [Related]
4. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
Shaw RW
Fertil Steril; 1992 Aug; 58(2):265-72. PubMed ID: 1386029
[TBL] [Abstract][Full Text] [Related]
5. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.
Venturini PL; Fasce V; Costantini S; Anserini P; Cucuccio S; de Cecco L
Fertil Steril; 1990 Dec; 54(6):1021-7. PubMed ID: 2147154
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced prostatic carcinoma with a slow release depot LHRH analogue (Zoladex depot).
Lukkarinen O; Kontturi M
Scand J Urol Nephrol Suppl; 1988; 110():109-12. PubMed ID: 2973121
[TBL] [Abstract][Full Text] [Related]
7. LHRH analogue for treatment of recurrent and refractory mastalgia.
Hamed H; Caleffi M; Chaudary MA; Fentiman IS
Ann R Coll Surg Engl; 1990 Jul; 72(4):221-4. PubMed ID: 2143364
[TBL] [Abstract][Full Text] [Related]
8. [Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
Kuber W; Treu T; Kratzik C; Girsch E; Zeillinger R; Spona J
Wien Klin Wochenschr; 1990 Nov; 102(21):640-7. PubMed ID: 2148044
[TBL] [Abstract][Full Text] [Related]
9. An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
Robinson MR; Denis L; Mahler C; Walker K; Stitch R; Lunglmayr G
Eur J Surg Oncol; 1985 Jun; 11(2):159-65. PubMed ID: 3159598
[TBL] [Abstract][Full Text] [Related]
10. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
[No Abstract] [Full Text] [Related]
11. Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosis.
Mettler L; Steinmüller H; Schachner-Wünschmann E
Hum Reprod; 1991 May; 6(5):694-8. PubMed ID: 1834693
[TBL] [Abstract][Full Text] [Related]
12. Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
Kaufmann M; Jonat W; Kleeberg U; Eiermann W; Jänicke F; Hilfrich J; Kreienberg R; Albrecht M; Weitzel HK; Schmid H
J Clin Oncol; 1989 Aug; 7(8):1113-9. PubMed ID: 2526863
[TBL] [Abstract][Full Text] [Related]
13. [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].
Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Akaza H; Niijima T; Aso Y; Araki T; Itatani H
Hinyokika Kiyo; 1988 Oct; 34(10):1853-63. PubMed ID: 2977527
[TBL] [Abstract][Full Text] [Related]
14. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Lamberts SW; Uitterlinden P; de Jong FH
Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
[TBL] [Abstract][Full Text] [Related]
15. [Treatment with the LH-RH agonist (Zoladex depot) in patients with puberty praecox].
Bassi F; Serio M
Drugs Exp Clin Res; 1990; 16 Suppl():33-7. PubMed ID: 2150502
[No Abstract] [Full Text] [Related]
16. Zoladex in the treatment of premenopausal metastatic breast cancer patients.
Kaufmann M
Horm Res; 1989; 32 Suppl 1():202-5. PubMed ID: 2533150
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
Stevenson JC; Lees B; Gardner R; Shaw RW
Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
[TBL] [Abstract][Full Text] [Related]
18. Clinical appreciation of LHRH analogue formulations.
Lemay A
Horm Res; 1989; 32 Suppl 1():93-101; discussion 102. PubMed ID: 2533161
[TBL] [Abstract][Full Text] [Related]
19. Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.
Ahmed SR; Grant J; Shalet SM; Howell A; Chowdhury SD; Weatherson T; Blacklock NJ
Br Med J (Clin Res Ed); 1985 Jan; 290(6463):185-7. PubMed ID: 3155636
[TBL] [Abstract][Full Text] [Related]
20. A new longer-acting LHRH analog depot: preliminary results of a Dutch open phase II clinical study on a 10.8 mg Zoladex 3-monthly depot.
Dijkman GA; Fernandez del Moral P; Plasman JW; Pull HC; van der Meijden AP; Debruyne FM; Hutchinson FG; Furr BJ
Eur Urol; 1990; 18 Suppl 3():22-5. PubMed ID: 2151271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
